US EditionTrump delays threatened 100 percent tariffs on drugs
The Trump administration delayed 100% tariffs on imported branded drugs to allow negotiations, with Pfizer agreeing to invest $70 billion to boost U.S. manufacturing.
- On October 1, the Trump administration delayed the 100% tariffs on some imported drugs, pausing them while proposals are evaluated; the tariffs were originally set to start Wednesday.
- After launching an April 1 trade investigation, the administration said the tariffs aim to lower prices and push companies building plants in the United States.
- Pfizer pledged $70 billion and agreed to lower drug prices under a deal with the administration, joining TrumpRx.gov and securing a three-year pause on tariffs.
- Pharmacists including Kate Riddell warned tariffs could cause access and pricing issues, while local observers said the Pfizer deal may relieve patients and pharmacists as shares of Eli Lilly, Amgen, Roche and GSK rose on Wednesday.
- A Johns Hopkins Carey Business School study found tariffs would likely push branded manufacturers to relocate some operations to the U.S., and officials said duties targeted certain brand-name medications including some eye drops.
17 Articles
17 Articles
100% duties on imports of drugs into the United States, announced last week by US President Donald Trump with entry into force scheduled on 1 October, will not enter into force yet. This has been confirmed by a senior government official at the German press agency Dpa
India US Relation: Last week, US President Donald Trump announced a 100% tariff on imports of branded and patented medicines.
White House delays 100% drug tariffs amid price talks
The 100% tariffs on some imported drugs have been delayed.President Donald Trump threatened to impose the tariffs on brand-name or patented drugs last week. He said the tariffs would not apply to drugmakers that are building manufacturing plants in the U.S.The tariffs were set to go into effect Wednesday, but a White House official said they will not be levied while the administration evaluates companies proposals to reduce prices and increase U…
Trump tariff threats punch holes in UK trade deal
LONDON — Keir Starmer thought he had an enduring trade pact with the U.S. to lower tariffs. Donald Trump appears to have other ideas. A flurry of new tariff announcements on pharma, trucks and movies have left British officials scrambling to keep up — and exposed holes in the trade deal Starmer and Trump struck in May. “I think it was a better deal for you than us, but these are minor details,” Trump told Starmer during a press conference amid t…
Coverage Details
Bias Distribution
- 62% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
